Hypo-Stream Ltd is an emerging biopharma company based in Cambridge, UK. Founded in 2009, the company is dedicated to addressing conditions with combined infectious and inflammatory processes, driven by a commitment to enhancing patients' quality of life. Hypo-Stream's primary focus lies in developing treatments for severe burns and ARDS, with the potential to expand into other inflammatory diseases involving IL-6.
Currently, there is no information available regarding the last investment or the investors involved in Hypo-Stream Ltd. However, the company's strategic positioning and its pioneering approach to biopharmaceuticals make it an intriguing prospect for potential venture capital investment.
There is no investment information
No recent news or press coverage available for Hypo-Stream Ltd.
-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
